These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20694939)

  • 21. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.
    Lambert M; Naber D; Schacht A; Wagner T; Hundemer HP; Karow A; Huber CG; Suarez D; Haro JM; Novick D; Dittmann RW; Schimmelmann BG
    Acta Psychiatr Scand; 2008 Sep; 118(3):220-9. PubMed ID: 18699954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in patients with schizophrenia: A prospective, multi-center study.
    Xiang YT; Wang CY; Weng YZ; Bo QJ; Chiu HF; Zhao JP; Liu TQ; Chan SS; Lee EH; Ungvari GS
    Psychiatry Res; 2010 May; 177(3):294-8. PubMed ID: 20417572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
    Novick D; Haro JM; Suarez D; Vieta E; Naber D
    Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance of recovery from schizophrenia at 20-year follow-up: what happened?
    Torgalsbøen AK; Rund BR
    Psychiatry; 2010; 73(1):70-83. PubMed ID: 20235619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
    Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
    Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a clinical pathway for long-term inpatients with schizophrenia.
    Nakanishi M; Sawamura K; Sato S; Setoya Y; Anzai N
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):99-103. PubMed ID: 20416029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yoga therapy as an add-on treatment in the management of patients with schizophrenia--a randomized controlled trial.
    Duraiswamy G; Thirthalli J; Nagendra HR; Gangadhar BN
    Acta Psychiatr Scand; 2007 Sep; 116(3):226-32. PubMed ID: 17655565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: a naturalistic 6-month follow-up study.
    Wittorf A; Sickinger S; Wiedemann G; Klingberg S
    Arch Clin Neuropsychol; 2008 May; 23(3):271-82. PubMed ID: 18272323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
    Helldin L; Kane JM; Hjärthag F; Norlander T
    Schizophr Res; 2009 Nov; 115(1):67-73. PubMed ID: 19666215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Haro JM; Altamura C; Corral R; Elkis H; Evans J; Krebs MO; Zink M; Malla A; Méndez JI; Bernasconi C; Lalonde J; Nordstroem AL
    Psychiatry Res; 2018 Sep; 267():56-62. PubMed ID: 29883861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of remission and recovery in schizophrenia in the Czech Republic.
    Prikryl R; Kholova M; Kucerova HP; Ceskova E
    Compr Psychiatry; 2013 Oct; 54(7):1111-6. PubMed ID: 23810077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission.
    Bobes J; Ciudad A; Alvarez E; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Nov; 115(1):58-66. PubMed ID: 19729283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y, social function and long-term outcome in schizophrenia.
    Stålberg G; Ekselius L; Lindström LH; Larhammar D; Bodén R
    Schizophr Res; 2014 Jul; 156(2-3):223-7. PubMed ID: 24799298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.